Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gastrografin oral solution
1803000A0BBABAA
|
Proprietary compound preparation BNF 1803000 | Other x-ray contrast media preparations | Preparations used in Diagnosis | 32 |
|
Meg amido 3.3g/Sod amido 500mg/5ml soln SF
1803000A0AAAAAA
|
Generic compound preparation BNF 1803000 | Other x-ray contrast media preparations | Preparations used in Diagnosis | 1 |
|
Biloptin 500mg capsules
180300000BMAHA0
|
Proprietary compound preparation BNF 1803000 | Other x-ray contrast media preparations | Preparations used in Diagnosis | No data available |
|
Pentagastrin 500micrograms/2ml inj ampoules
180400000AABABA
|
Generic compound preparation BNF 1804000 | Other diagnostic agent preparations | Preparations used in Diagnosis | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.